Living with Pancreatic Cancer
736 articles
Can I exercise? How can I cope with stress and anxiety? Learn more here.
Treating BRCA-Negative Pancreatic Cancer Patients with a Family Cancer History Similar to BRCA Carriers
A clinical trial looks at the effectiveness of a PARP inhibitor in BRCA-negative pancreatic cancer patients with a family history BRCA-type cancers.
Reading the Scientific Study to Understand a Pancreatic Cancer Treatment
How can you tell if a scientific study is good? Learn what to look for in reliable studies and whether there may be a trial to pursue.
Clinical Trial of Immunotherapy Plus Sunshine Vitamin May Help in Pancreatic Cancer Fight
Can vitamin D make it easier for chemotherapy drugs to reach the pancreatic cancer tumor? A clinical trial is testing this idea.
The Link Between Pancreatic Cancer and Diabetes
Dr. Suresh Chari of the Mayo Clinic has spent a good part of his career looking at the relationship between pancreatic cancer and diabetes.
Surviving Pancreatic Cancer and Embracing Life
Joel Evans’ endocrinologist was concerned so he sent him to get tested for pancreatic cancer. It was caught early enough for a Whipple procedure.
Don’t Ignore Your Symptoms
It took Ed Duncan a long time to recognize that the symptoms he had added up to a very serious disease: pancreatic cancer.
Surviving Pancreatic Cancer Three Times
Jaundice brought Larry Nicolet to the doctor but took three tries, including a Whipple procedure, for him to be clean of pancreatic cancer.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
The Cancer Moonshot
Dr. Elizabeth Jaffee of Johns Hopkins is part of the Cancer Moonshot’s Blue Ribbon Panel, and she explains the goals of the program.
Learning to Guide My Pancreatic Cancer Treatment
The more Colin Gabriel learned about pancreatic cancer, the more he realized he needed to guide his treatment, rather than go where his HMO recommended.
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.
Summer Safety for Pancreatic Cancer Patients
In the heat of the summer, pancreatic cancer patients face summer safety challenges so they don’t overheat, burn, or exhaust themselves.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.